Yunnan Jianfeng conducts emergency drill for ammonia leakage accident
Release time:
2020-08-14
Yunnan Jianfeng Conducted Emergency Drill for Ammonia Leakage Accident
News In order to further improve the on-site handling capacity of ammonia leakage accident and timely control and eliminate the harm of ammonia leakage accident, Yunnan Jianfeng Cement Company carried out emergency rescue drill for ammonia leakage accident on August 9, 23, July 6. This exercise simulated the scene of leakage of ammonia tank valve and ammonia overflow at the end of the kiln: during the routine inspection of ammonia tank area, the on-duty post did not wear protective equipment to enter the tank area as required. due to sudden leakage of ammonia in the tank area, the on-duty post inspection withdrew from the tank area in time, but excessive ammonia inhalation caused nausea, irritation and dyspnea, sending a distress signal to the central control. At the same time, the central control operator found that the denitration system at the end of the kiln was stopped, and the alarm showed that the ammonia concentration in the ammonia tank area exceeded the standard. Upon receiving the post inspection distress signal, the central control operator immediately reported to the workshop management personnel and the safety and environmental protection department, and notified the adjacent post workers on site to confirm the cause of the failure.
"accident", Yunnan peak the first time to start the emergency rescue plan. The ammonia leakage emergency response team led by clinker supervisor Xiong Guoyun wore complete protective equipment and entered the leakage area to check the leakage. It was found that a valve was not closed tightly, causing ammonia leakage. After closing the valve to confirm that there is no continuous leakage, open the water pipe nozzle in the ammonia tank area to spray water, and the sprinkler will flush the leaking part to dilute the ammonia concentration and reduce the danger degree during personnel handling. At the same time, arrange the employees wearing safety protective clothing to open the discharge valve and discharge the ammonia in the tank into the accident pool. Finally, the emergency team tested the surrounding water quality and air to confirm the standard, and the exercise was successfully completed. After the
exercise, exercise commander Zhou Jiping commented on the problems exposed during the exercise and summarized and guided them. (Liu Fengbin /
Shi Wenting /) How to save yourself when
ammonia leaks?
Ammonia is an aqueous solution of ammonia. After inhalation, it is irritating to the nose, throat and lungs. It can cause cough, shortness of breath and asthma. It can suffocate due to throat edema and death. Pulmonary edema can cause death. Ammonia splashes into the eyes can cause serious damage and even blindness, skin contact can cause burns.
In case of ammonia gas or ammonia water leakage, if the personnel have skin contact, they should immediately wash with water for at least 15
15 minutes, or rinse with 3% boric acid solution, and then seek medical attention immediately. Those who inhale ammonia should quickly escape from the scene to a place with fresh air to keep the respiratory tract unobstructed. If someone ingested or inhaled the substance, other people do not use mouth-to-mouth artificial respiration. Use a one-way valve small respirator or other appropriate medical respirator for artificial respiration.
People who take ammonia by mistake should rinse their mouth immediately, take diluted vinegar or lemon juice orally, and then seek medical attention immediately. (Liu Fengbin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31